MoonLake Immunotherapeutics
MLTX
$16.47
-$0.03-0.18%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 26.34% | -25.45% | -12.07% | -22.97% | -18.22% |
| Total Receivables | 92.46% | 92.87% | 71.20% | 67.09% | 103.30% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -2.01% | 42.39% | -2.40% | 67.13% | 75.19% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 25.15% | -21.65% | -11.09% | -19.73% | -15.16% |
|
|
|||||
| Total Current Assets | 25.15% | -21.65% | -11.09% | -19.73% | -15.16% |
| Net Property, Plant & Equipment | -12.10% | -27.61% | -41.19% | -33.91% | -24.54% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -20.80% | -20.85% | -- | -71.57% | -58.90% |
| Total Assets | 24.75% | -21.69% | -11.19% | -20.05% | -15.56% |
|
|
|||||
| Total Accounts Payable | 2,730.23% | 166,900.00% | 100.55% | 361.81% | 241.27% |
| Total Accrued Expenses | 1.60% | 0.57% | 111.11% | 150.98% | 144.84% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -19.61% | -35.75% | -10.06% | 3.74% | 17.27% |
| Total Finance Division Other Current Liabilities | 180.62% | -37.50% | 70.40% | 109.29% | 0.82% |
| Total Other Current Liabilities | 180.62% | -37.50% | 70.40% | 109.29% | 0.82% |
| Total Current Liabilities | 65.90% | 92.29% | 102.46% | 140.86% | 122.77% |
|
|
|||||
| Total Current Liabilities | 65.90% | 92.29% | 102.46% | 140.86% | 122.77% |
| Long-Term Debt | 35.61% | 35.60% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -7.66% | -24.26% | -74.35% | -74.89% | -58.66% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -87.11% | -34.14% | -- | -21.01% | 5.92% |
| Total Liabilities | 42.68% | 48.31% | 388.76% | 442.21% | 588.07% |
|
|
|||||
| Common Stock & APIC | 49.42% | 15.52% | 13.19% | 2.04% | 1.78% |
| Retained Earnings | -79.72% | -93.30% | -96.49% | -110.79% | -113.95% |
| Treasury Stock & Other | 21.15% | -86.51% | -87.91% | -90.19% | -84.03% |
| Total Common Equity | 21.05% | -37.67% | -31.86% | -40.82% | -32.06% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 21.05% | -37.67% | -31.86% | -40.82% | -32.06% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -68.73% | -55.03% |
| Total Equity | 19.63% | -38.43% | -32.84% | -41.23% | -32.47% |
|
|
|||||